102 related articles for article (PubMed ID: 12697079)
1. Aminoglycosides for intra-abdominal infection: equal to the challenge?
Bailey JA; Virgo KS; DiPiro JT; Nathens AB; Sawyer RG; Mazuski JE
Surg Infect (Larchmt); 2002; 3(4):315-35. PubMed ID: 12697079
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials.
Vidal L; Gafter-Gvili A; Borok S; Fraser A; Leibovici L; Paul M
J Antimicrob Chemother; 2007 Aug; 60(2):247-57. PubMed ID: 17562680
[TBL] [Abstract][Full Text] [Related]
3. The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials.
Falagas ME; Matthaiou DK; Bliziotis IA
J Antimicrob Chemother; 2006 Apr; 57(4):639-47. PubMed ID: 16501057
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis: randomized controlled trials of clindamycin/aminoglycoside vs. beta-lactam monotherapy for the treatment of intra-abdominal infections.
Falagas ME; Matthaiou DK; Karveli EA; Peppas G
Aliment Pharmacol Ther; 2007 Mar; 25(5):537-56. PubMed ID: 17305755
[TBL] [Abstract][Full Text] [Related]
5. Aminoglycoside drugs in clinical practice: an evidence-based approach.
Leibovici L; Vidal L; Paul M
J Antimicrob Chemother; 2009 Feb; 63(2):246-51. PubMed ID: 19022778
[TBL] [Abstract][Full Text] [Related]
6. Use of aminoglycosides in surgical infections.
Stone HH; Kolb LD; Geheber CE; Dawkins EJ
Ann Surg; 1976 Jun; 183(6):660-6. PubMed ID: 973753
[TBL] [Abstract][Full Text] [Related]
7. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: evidence for the recommendations.
Mazuski JE; Sawyer RG; Nathens AB; DiPiro JT; Schein M; Kudsk KA; Yowler C;
Surg Infect (Larchmt); 2002; 3(3):175-233. PubMed ID: 12542923
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of three antimicrobial drugs protocol (Ceftriaxone, Gentamicin/Amikacin and Metronidazole) versus two antimicrobial drugs protocol (Ceftriaxone and Metronidazole) in cases of intra-abdominal sepsis.
Khan S; Gupta DK; Khan DN
Kathmandu Univ Med J (KUMJ); 2005; 3(1):55-63. PubMed ID: 16401946
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis: ertapenem for complicated intra-abdominal infections.
Falagas ME; Peppas G; Makris GC; Karageorgopoulos DE; Matthaiou DK
Aliment Pharmacol Ther; 2008 May; 27(10):919-31. PubMed ID: 18266994
[TBL] [Abstract][Full Text] [Related]
10. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials.
Falagas ME; Vouloumanou EK; Togias AG; Karadima M; Kapaskelis AM; Rafailidis PI; Athanasiou S
J Antimicrob Chemother; 2010 Sep; 65(9):1862-77. PubMed ID: 20587612
[TBL] [Abstract][Full Text] [Related]
11. Systemic review and meta-analysis of randomized clinical trials comparing primary vs delayed primary skin closure in contaminated and dirty abdominal incisions.
Bhangu A; Singh P; Lundy J; Bowley DM
JAMA Surg; 2013 Aug; 148(8):779-86. PubMed ID: 23803860
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of doripenem vs comparators in patients with pseudomonas infections enrolled in four phase III efficacy and safety clinical trials.
Jenkins SG; Fisher AC; Peterson JA; Nicholson SC; Kaniga K
Curr Med Res Opin; 2009 Dec; 25(12):3029-36. PubMed ID: 19849650
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic trials in intra-abdominal infections. A critical evaluation of study design and outcome reporting.
Solomkin JS; Meakins JL; Allo MD; Dellinger EP; Simmons RL
Ann Surg; 1984 Jul; 200(1):29-39. PubMed ID: 6375597
[TBL] [Abstract][Full Text] [Related]
14. Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.
Tellado J; Woods GL; Gesser R; McCarroll K; Teppler H
Surg Infect (Larchmt); 2002; 3(4):303-14. PubMed ID: 12697078
[TBL] [Abstract][Full Text] [Related]
15. Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials.
Bliziotis IA; Samonis G; Vardakas KZ; Chrysanthopoulou S; Falagas ME
Clin Infect Dis; 2005 Jul; 41(2):149-58. PubMed ID: 15983909
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic therapy in intra-abdominal infections--a review on randomised clinical trials.
Holzheimer RG; Dralle H
Eur J Med Res; 2001 Jul; 6(7):277-91. PubMed ID: 11485888
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of two comparative antibiotic regimens in the treatment of serious intra-abdominal infections: results of a multicenter study.
Eckhauser FE; Knol JA; Raper SE; Mulholland MW; Helzerman P
Clin Ther; 1992; 14(1):97-109. PubMed ID: 1576632
[TBL] [Abstract][Full Text] [Related]
18. Cefotetan in the treatment of serious intra-abdominal sepsis: a controlled clinical trial.
Scott SD; Karran SJ
Int J Clin Pharmacol Res; 1987; 7(3):229-31. PubMed ID: 3298087
[TBL] [Abstract][Full Text] [Related]
19. Clinical trials of extended spectrum penicillin/beta-lactamase inhibitors in the treatment of intra-abdominal infections. European and North American experience.
Wilson SE; Nord CE
Am J Surg; 1995 May; 169(5A Suppl):21S-26S. PubMed ID: 7755164
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial [corrected] coating of abdominal closure sutures and wound infection.
Justinger C; Moussavian MR; Schlueter C; Kopp B; Kollmar O; Schilling MK
Surgery; 2009 Mar; 145(3):330-4. PubMed ID: 19231586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
